This inventor holds 1 USPTO granted patent. Top assignee: Alter, S.a.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Mariano Sanchez-Crespo: Innovator in Pharmaceutical Chemistry
Introduction
Mariano Sanchez-Crespo is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds with PAF-antagonist activity. His research has implications for various medical applications, showcasing the importance of his inventions in the healthcare sector.
Latest Patents
Mariano Sanchez-Crespo holds a patent for "4-alkyl-1,4-dihydropyridines with PAF-antagonist activity." This patent describes compounds of formula (I), where R is saturated C1-C4, R' is saturated C1-C6 alkyl, which may be interrupted by an oxygen atom, or 2-tetrahydrofurfuryl, and R² is saturated C1-C4 or phenyl. The specific compound wherein R is methyl, R' is ethyl, and R² is phenyl is excluded. These compounds are prepared through various reactions involving different chemical precursors. The compounds are particularly useful due to their antagonist activity of the platelet activating factor.
Career Highlights
Mariano Sanchez-Crespo is associated with Alter, S.A., where he continues to advance his research and development efforts. His work has led to the creation of valuable pharmaceutical compounds that contribute to the understanding and treatment of various medical conditions.
Collaborations
Throughout his career, Mariano has collaborated with esteemed colleagues such as Carlos Sunkel and Miguel Fau De Casa-Juana. These collaborations have fostered a productive environment for innovation and have enhanced the impact of their collective research efforts.
Conclusion
Mariano Sanchez-Crespo is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His patent on 4-alkyl-1,4-dihydropyridines exemplifies his commitment to innovation and the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile